UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000029070
Receipt No. R000033247
Scientific Title The neonatal outcomes of Dexamethasone administration before scheduled cesarean delivery at term: A randomized clinical trial
Date of disclosure of the study information 2018/05/01
Last modified on 2019/09/11 (Ver. 13)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The neonatal outcomes of Dexamethasone administration before scheduled cesarean delivery at term: A randomized clinical trial
Acronym Antenatal steroids before elective cesarean section: Randomized clinical trial
Scientific Title The neonatal outcomes of Dexamethasone administration before scheduled cesarean delivery at term: A randomized clinical trial
Scientific Title:Acronym The neonatal outcomes of Dexamethasone administration before scheduled cesarean delivery at term: A randomized clinical trial
Region
Africa

Condition
Condition recruiting
Classification by specialty
Obsterics and gynecology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 evaluation of the role of giving steroids before elective cs for full term baby
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Explanatory
Developmental phase Phase IV

Assessment
Primary outcomes neonatal outcomes: Occurrence of RDS, TTN or other respiratory morbidities and the need for incubation or NICU
Key secondary outcomes Maternal outcome: Wound healing

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification NO
Dynamic allocation YES
Institution consideration Institution is not considered as adjustment factor.
Blocking YES
Concealment Numbered container method

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Medicine
Interventions/Control_1 Receive dexamethasone 8mg IM/12 hours for 3 doses with the last dose at least 24 hours before elective cs
Interventions/Control_2 Receive saline 0.9% 2ml IM/12 hours for 4 doses with the last dose at least 24 hours before elective cs
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
40 years-old >=
Gender Female
Key inclusion criteria Age 20-40years
elective cs
full term baby>=37weeks
Key exclusion criteria selective CS
malformed baby
immature bay
refusal to participate
Target sample size 400

Research contact person
Name of lead principal investigator
1st name Ayman
Middle name Shehata
Last name Dawood
Organization Tanta University
Division name Ayman shehata dawood
Zip code 31111
Address Tanta university
TEL +201020972067
Email ayman.dawood@med.tanta.edu.eg

Public contact
Name of contact person
1st name Ayman
Middle name Shehata
Last name Dawood
Organization Tanta university
Division name Marwa saad
Zip code 31111
Address Tanta university
TEL 00201010477601
Homepage URL
Email ayman.dawood@med.tanta.edu.eg

Sponsor
Institute Tanta University
Obstetrics and gynecology department
Institute
Department

Funding Source
Organization self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Tanta University
Address Elgeish st., Tanta, Egypt
Tel +201020972067
Email qau@med.tanta.edu.eg

Secondary IDs
Secondary IDs YES
Study ID_1 Ayman Shehata dawood
Org. issuing International ID_1 Tanta University
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 05 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 400
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 11 Month 01 Day
Date of IRB
2017 Year 10 Month 01 Day
Anticipated trial start date
2018 Year 01 Month 01 Day
Last follow-up date
2018 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
2019 Year 01 Month 01 Day
Date analysis concluded
2019 Year 02 Month 04 Day

Other
Other related information

Management information
Registered date
2017 Year 09 Month 08 Day
Last modified on
2019 Year 09 Month 11 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033247